A randomized study of the safety and antiretroviral activity of hydroxyurea combined with didanosine in persons infected with human immunodeficiency virus type 1. American Foundation for AIDS Research Community-Based Clinical Trials Network.

Hellinger, J A; Iwane, M K; Smith, J J; Fleishman, A N; Torres, R A; Schrader, S; Perez, G; Cohen, C J; Skowron, G; Giordano, M F; Accetta, G; Cooper, E C; Frost, K R

Hellinger, J A; Iwane, M K; Smith, J J; Fleishman, A N; Torres, R A; Schrader, S; Perez, G; Cohen, C J; Skowron, G; Giordano, M F; Accetta, G; Cooper, E C; Frost, K R.

Affiliation

Hellinger JA; Community Research Initiative of New England, Brookline, Massachusetts, USA.

J Infect Dis ; 181(2): 540-7, 2000 Feb.

Article in En | MEDLINE | ID: mdl-10669337

Subject(s)

Anti-HIV Agents/therapeutic use; Didanosine/therapeutic use; HIV Infections/drug therapy; HIV-1/drug effects; Hydroxyurea/therapeutic use; Adult; CD4 Lymphocyte Count; DNA, Viral/blood; Drug Therapy, Combination; Female; HIV Infections/immunology; HIV Infections/virology; HIV-1/physiology; Humans; Male; Nucleic Acid Synthesis Inhibitors/therapeutic use; Reverse Transcriptase Inhibitors/therapeutic use; Viral Load

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: HIV Infections / HIV-1 / Didanosine / Anti-HIV Agents / Hydroxyurea Type of study: Clinical_trials Limits: Adult / Female / Humans / Male Language: En Journal: J Infect Dis Year: 2000 Document type: Article Affiliation country: United States Country of publication: United States

Search on Google

Add to My VHL

XML

PubMed Links